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Abstract—Interstitial fluid pressure (IFP), interstitial fluid
velocity (IFV), interstitial permeability (IP) and vascular per-
meability (VP) are cancer mechanopathological parameters of
great clinical significance. To date, there is a lack of non-invasive
techniques that can be used to estimate these parameters in
vivo. In this study, we designed and tested new ultrasound
poroelastography methods capable of estimating the magnitude
and spatial distribution of fluid pressure, fluid velocity and fluid
flow inside tumors. We theoretically proved that fluid pressure,
velocity and flow estimated using poroelastography from a tumor
under creep compression are directly related to the underlying
IFP, IFV and fluid flow, respectively, differing only in peak
values. We also proved that, from the spatial distribution of the
fluid pressure estimated using poroelastography, it is possible to
derive: the parameter , which quantifies the spatial distribution
of the IFP; the ratio between VP and IP and the ratio between the
peak IFP and effective vascular pressure in the tumor. Finally, we
demonstrated that axial strain time constant (TC) elastograms
are directly related to VP and IP in tumors. Our techniques were
validated using finite element and ultrasound simulations, while
experiments on a human breast cancer animal model were used
to show the feasibility of these methods in vivo.
Index Terms—Elastography, cancer imaging, interstitial
fluid pressure, fluid velocity, tumor microenvironment, tumor
mechanopathology
I. INTRODUCTION
The cancer mechanical microenvironment plays an impor-
tant role in the tumor’s growth, invasion and metastasis [1]–
[3]. The main components of the cancer mechanical microen-
vironment are the interstitial fluid pressure (IFP) and the solid
stress [2], [4]. There are a number of factors that contribute
to the elevated IFP inside a tumor. These factors include
blood-vessel leakiness, lymph-vessel abnormalities, interstitial
fibrosis and a contraction of the interstitial space mediated
by stromal fibroblasts [5], while the uncontrolled proliferation
of the cancer cells and the electrostatic force among the
negatively charged hyaluronan chains are the main causes for
the development of the solid stress inside the tumor [4].
IFP is a parameter of great clinical significance. IFP inside
cancers has been identified as one of the major barriers to
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cancer treatments [5], [6]. In chemo- and immune-therapy,
interstitial fluid flow from the center to the periphery of the
tumor induced by the IFP prevents drug molecules to reach the
core of the tumor, thus affecting the efficacy and uniformity
of drug diffusion in the cancer mass [7], [8]. Interstitial hyper-
tension caused by IFP can cause failure to radiation therapy
by increasing cell clonogenicity and VEGF-A expression in
tumor tissue [9]. Interstitial fluid flow due to IFP may also
promote metastasis, by increasing the shear stress acting on the
cancer cells and forcing them to move toward the lymphatic
system adjacent to the solid tumor [7], [10]. Due to elevated
IFP in cancers, the lymphatic channels inside the tumor are
hampered [10] reducing the outflow of fluids from the tumor.
All the above phenomena created because of elevated IFP
inside the tumor expedite cancer progression, metastasis and
reduce therapeutic success. Moreover, IFP has been proved to
be a valuable diagnostic and prognostic marker for many types
of cancers [11], [12]. Therefore, an imaging method capable
of accurately and non-invasively assess IFP in tumors would
be of great clinical importance, but it has not been realized
yet.
In the past years, several models have been proposed to
describe and predict the behavior of IFP in tumors. It has
been demonstrated that IFP ( ) inside a spherical tumor can
be written using the following expression [13]–[15]:
where
(1)
where is the effective vascular pressure. From this equation,
it is clear that the spatial distribution of the IFP in the tumor
is controlled by the parameter , which is related to the ratio
of VP and IP in the tumor [15]. The value of is clinically
important since the spatial distributions of IFP and IFV and
ratio between VP and IP can be used for diagnosis of cancers
and improve drug delivery therapies [7].
IFV is another important parameter for targeted delivery
therapies [7]. IFV is created by the gradient of the IFP from
the center to the periphery of the tumor. High IFV inside the
tumor is directly related to high intratumor convection, which
may facilitate distribution and penetration of drugs throughout
the entire tumor [7]. On the other hand, high values of IFV at
the periphery of the tumor increase the convective loss of the
therapeutics and supply growth factors (VEGF-A and VEGF-
C) to surrounding tissues [7], which, in turn, increases the
2rate of neo-angiogenesis. Therefore, estimation of IFV inside
tumors can be useful in drug delivery and for determination
of the cancer stage.
IP and VP also carry important information about the tumor
mechanopathology. When a solid tumor grows, it initially
makes use of existing vasculature but then requires angiogene-
sis. The newly formed blood vessels are leaky, highly irregular
and tortuous [16], [17]. This process increases the VP of the
tumor and decreases its perfusion. The IP of the tumor differs
from the one of a normal tissue because the proliferation
rate of cancer cells results in increased cellular density and
collagen deposition in the tumor interstitium [7], [15]. VP and
IP modulate drug diffusion and accumulation at the tumor,
since they affect convection and consolidation times of the
molecules inside the cancer mass [15]. Moreover, knowledge
of VP inside the tumor can affect the choice of a treatment to
be administered. Vascular normalization treatments are more
effective in tumors with high VP, whereas stress normalization
treatments are more effective in tumors with low VP [18], [19].
In the past few decades, several invasive techniques have
been proposed to estimate the IFP in tumors. These include:
transducer-tipped catheter with a precision glide needle [20],
wick catheter [21], modified wick technique (wick-in-needle
technique) [22], [23], servo-micropipette [24] and subcuta-
neous capsule implantation for weeks [25]. Dynamic
contrast-enhanced magnetic resonance imaging (DCE-MRI)
has been explored in a small number of studies as a possible
tool to estimate IFP/IFV in tissues [26]–[29]. However, values
of IFP obtained from these studies show a weak correlation
with actual IFP values inside the tumor [27], [28], [30]. Given
their clinical importance, IFP and IFV have been extensively
investigated both theoretically and experimentally [7], [15],
[31]. The spatial parameter of the IFP has been studied in
Refs. [15], [32] and estimated in Ref. [33] using least square
fit on the spatial distribution of IFP. However, similarly to IFP
and IFV, can only be experimentally assessed using invasive
techniques or expensive contrast-based imaging techniques.
Ultrasound poroelastography is a cost-effective, non-
invasive imaging modality that can be used to measure time-
dependent strain fields generated in a tissue in response to
an externally applied stress [34], [35]. The motivation behind
poroelastography is that underlying pathologies such as can-
cers and lymphedema affect the established fluid pressure gra-
dients and, as such, the induced strains. Fluid pressure created
by the applied tissue compression is an important parameter
in poroelastography, which affects the resulting displacements,
stresses and strains inside the tissue [35]. In this paper, we
provide a direct link between the parameters obtained from a
poroelastography experiment and the underlying IFP, IFV, fluid
flow, VP and IP in the tumor. We first developed analytical
formulations to estimate the fluid pressure, fluid velocity,
fluid flow, , ratio between VP and IP and ratio between
peak IFP and effective vascular pressure from experimental
poroelastography data. Then, we mathematically proved that:
1) the spatial parameter of the fluid pressure induced by the
applied stress is identical to the spatial parameter of the IFP;
2) the fluid pressure, fluid velocity and fluid flow estimated
using ultrasound poroelastography are the weighted versions of
the IFP, IFV and the fluid flow inside the tumor, respectively;
and 3) the ratio between VP and IP and the ratio between
the peak IFP and effective vascular pressure in the tumor
can be estimated from value of . The theoretical models
were validated using finite element and ultrasound simulations
while the clinical feasibility of the proposed methods was
demonstrated in a human triple negative breast cancer animal
model before and after treatment.
II. THEORIES BEHIND THE PROPOSED IMAGING
TECHNIQUES
The developed theories for estimation of fluid pressure,
fluid velocity, fluid flow, , ratio between VP and IP and
ratio between peak IFP and effective vascular pressure in a
poroelastic material subjected to a creep compression (i.e.,
poroelastography experiment) are based on two assumptions:
1) Tumor and normal tissue are poroelastic materials, and
they can be modeled as biphasic materials, containing
two distinct phases, i.e., a solid phase and a fluid phase.
2) Tumors are of spherical shape and biphasic theory in
spherical coordinates can be applied to analyze their
poroelastic response to external compression.
The analytical formulations for the estimation of the differ-
ent parameters are given below.
A. Fluid pressure
The fluid pressure inside the tumor at radial position and
time can be written as
(2)
where is the compression modulus of the tumor and
is the volumetric strain inside the tumor estimated from
poroelastography experiments.
B. Ratio between vascular permeability and interstitial per-
meability and parameter
By solving the continuity equation of pore fluid in a
poroelastic material, when the fluid pressure is zero at the
periphery of a tumor, the equation for the fluid pressure inside
the tumor can be written as (see section 1 of the supplementary
information 1)
where (3)
Here is a constant related to the peak fluid pressure
as cosech and is the radius of the
tumor. is the VP, is the IP and is the surface area
to volume ratio of the capillary walls inside the tumor. This
equation resembles the equation of IFP (eq. (1)), originally
derived in Refs. [13]–[15], except for the constant . In
eq. (3), the constant depends on the applied pressure in
the poroelastography experiments, whereas the constant in
1supplementary information is available in the supplementary files/ multi-
media tab
3the equation of IFP derived in Refs. [13]–[15] can be written
as , where is the microvascular
pressure, and and are the plasma osmotic pressure and
the interstitial osmotic pressure, respectively.
The parameter can be estimated by fitting the fluid
pressure data (estimated using eq. (2)) with the theoretical
equation of fluid pressure (eq. (3)). Using the value of the
radius of the tumor and the surface area to volume ratio of the
capillary walls, it is possible to determine the ratio between
the VP and IP by knowledge of .
C. Ratio between peak IFP and effective vascular pressure
The ratio between the peak IFP and effective vascular
pressure can be expressed as
cosech (4)
Using the estimated value of in eq. (4), the ratio between the
peak IFP and effective vascular pressure can be determined.
D. Fluid velocity
The permeability-normalized fluid velocity with respect to
the solid along the radial direction inside a tumor can be
written as
(5)
As the fluid pressure is the weighted version of IFP (eq. (3)),
the fluid velocity is also the weighted version of the IFV.
E. Fluid flow
We can write the equation for the fluid flow occurring in
the tumor during a poroelastography experiment as
(6)
Alternatively, the fluid flow can be expressed as the gradient
of the fluid velocity occurring during a poroelastography ex-
periment multiplied by the porosity of the tumor (see section 1
of supplementary information). Similarly, the fluid flow inside
the tumor can be computed as the product of the gradient of
the IFV and the porosity of the tumor. Therefore, the fluid flow
occurring in the tumor during a poroelastography experiment
is the fluid flow inside the tumor multiplied by a constant
factor.
F. Axial strain time constant
The axial strain time constant can be defined as [35]
(7)
where is a constant, which depends on the Poisson’s ratio
and radius of the tumor. We see from eq. (7) that is inversely
proportional to the values of the IP and VP.
The detail proofs of eqs. (2)-(7) are shown in section 1 of
the supplementary information.
G. Validation of the proposed techniques
Estimation of the fluid pressure (eq. (2)), (eq. (3)) and
the fluid velocity (eq. (5)) using the proposed technique was
validated using finite element and ultrasound simulations as
reported in section 2 of the supplementary information. Fluid
flow and axial strain TC were not directly available from finite
element simulation software but were computed by established
theories from the literature [36], [37].
III. EXPERIMENTS
Mice implanted with triple negative breast cancer were
scanned once a week for three subsequent weeks. The cancers
were created by injecting cancer cells orthotopically in the
mammary fat pad of the mice [38]. In vivo experiments were
approved by the Houston Methodist Research Institute, Insti-
tutional Animal Care and Use Committee (ACUC-approved
protocol # AUP-0614-0033). Mice were kept untreated (n=6),
or treated with FEPI (Epirubicin alone, n=3), LEPI (liposomes
loaded with Epirubicin, n=3) and LEPILOX (liposomes loaded
with Epirubicin and conjugated with a targeting anti-LOX
antibody on the particle surface, n=3) for three weeks. The
dose of each drug was mg/kg body weight once a week. Mice
were individually scanned in dedicated ultrasound imaging
session. Each acquisition was minutes long, and several RF
data were obtained in the scan. For the experiment, mice were
anesthetized with isoflurane and kept lying on a thermostat-
regulated heating pad to prevent movement and discomfort.
Elastography was carried out using a -mm linear array
transducer (Sonix RP, Ultrasonix, Richmond, BC, Canada)
with a center frequency of 6.6 MHz, 5-14 MHz bandwidth.
To achieve a uniform surface geometry and improve focusing,
an aqueous ultrasound gel pad (Aquaflex, Parker Laboratories,
NJ, USA) was placed between the compressor plate and the
tumor mass. A force sensor (Tekscan FlexiForce) was placed
between the top surface of the gel pad and the compressor
plate to record the applied force during compression. Creep
experiments were performed on the animals by applying
manual compression, with the duration of each experiment
being one minute [39]. The ultrasound RF data acquisition was
synchronized to the application of compression. The sampling
rate of the data was configured as second/sample. The
axial and lateral strain data were calculated at a specific time
point by summing all the strains (between two consecutive
RF frames) from the start to end of that time point [40]. The
applied compressions in the creep experiments were inspected
using a graphical user interface software purchased with the
force sensor. The borders of the cancers were drawn from the
in vivo axial strain elastograms.
A. Estimation of axial and lateral displacements and strains
To compute the axial and lateral strain elastograms from
ultrasound pre- and post-compressed RF data, the method
proposed in Ref. [41] was used.
B. Estimation of Young’s modulus, Poisson’s ratio and axial
strain TC
For estimating the fluid pressure, estimation of the Young’s
modulus and Poisson’s ratio of the tumor is required, which
4was performed using the method described in Ref. [39].
Variable projection method proposed in Ref. [42] was used
to estimate the TC of the axial strain temporal curve.
C. Estimation of fluid pressure, velocity and flow
We used eqs. (2) and (5) to estimate the fluid pressure
and velocity from in vivo experimental data. We applied
a combination of Kalman and non-linear complex diffusion
filters on the axial and lateral strains to remove the noise
before computing the fluid pressure using them [43]. The
reconstructed fluid pressures and fluid velocities reported in
this paper are at time point of s. The fluid flow is computed
using eq. (6), i.e., by taking the time differential of the
volumetric strain with respect to two time points, i.e., s
and s ( ). The reconstructed fluid pressure,
fluid velocity and fluid flow were normalized by dividing
them by the applied pressure. Thus, they correspond to kPa
applied pressure, which ensured a fair comparison among these
parameters in treated and untreated tumors at the different time
points.
D. Estimation of
To determine the value of in vivo, we fit the fluid pressure
estimated from experimental strain data (from the center to
a radial direction) with the theoretical equation of the fluid
pressure (eq. (3)). We normalized the fluid pressure curve by
dividing it by the peak value and then fit eq. (3) onto it by
varying both and . Estimation of in this manner does
not require knowledge of . We used ‘Levenberg Marquardt’
algorithm in Matlab (Matlab Inc, Natick, MA, USA) as the
curve fitting algorithm. A smoothing filter of length pixels
was applied on the fluid pressure data before estimating the
.
E. Computation of surface area to volume ratio of the capil-
lary walls inside the tumor
For computing the surface area to volume ratio of the cap-
illary walls inside the tumor, we used the following equation
[44]
(8)
where is the volume of the tumor, which is computed as
, [44]. Here, is in units
of mm and is in units of cm .
F. Statistical Analysis
Data in Figs. 3 and 4 are presented as mean SD
(standard deviation). Matlab (MathWorks Inc., Natick, MA,
USA) was used to analyze the data. Statistical significance
was determined using the Kruskal-Wallis test.
IV. RESULTS
Fig. 1 shows B-mode images and corresponding recon-
structed fluid pressures, fluid velocities, fluid flows and axial
strain TC elastograms at three time points (week 1, week 2,
week 3) for an untreated tumor. The untreated tumor increased
in size with time as appreciable from the B-mode images (A1,
B1, C1). The fluid pressures (A2, B2, C2) appeared spatially
uniform especially at week 3. At week 1, the fluid velocity
was more than kPa per pixel in most of the regions inside
the tumor. In the second and third weeks, the fluid velocity
decreased and reached values close to zero in most of the
regions inside the tumor. The fluid flow (A4, B4, C4) reduced
with time from the first to the third week and overall exhibited
very low values in the second and third weeks.
The axial strain TC (A5, B5, C5) decreased with time in
the untreated tumor. As the effect of the IP is typically much
smaller than the effect of the VP in most tumors [7], [15], it is
reasonable to assume that the reduction in the axial strain TC
in the tumors was primarily due to changes in the aggregate
modulus or the VP (see eq. (7)). Based on the values of
Young’s modulus and Poisson’s ratio of this tumor in week
1, 2 and 3 (see Table I), the change in aggregate modulus
from week 1 to 3 was at most 1.5 folds. However, the overall
reduction of axial strain TC from the first to the third week
was about three times (90 to 30 s). Therefore, the decrease of
the axial strain TC value was mainly due to the increase of
VP, consistently with what has been previously reported [45].
B-mode images and reconstructed fluid pressures, fluid
velocities, fluid flows, axial strain TC elastograms in a treated
tumor are shown in Fig. 2. As a result of the treatment, tumor
decreased in size from week 1 to week 3 consistently with
what seen in B-mode images (A1, B1, C1). As opposed to
the untreated tumor, the fluid pressures (A2, B2, C2) inside
the treated tumor were space-dependent in all three weeks.
The fluid velocity (A3, B3, C3) increased with time in the
treated tumor. The values of fluid velocity also increased with
respect to the untreated one. Fluid flow (A4, B4, C4) was seen
increasing with time. When compared to the untreated tumors,
the value of fluid flow was also higher in the treated tumors.
The axial strain TC values (A5, B5, C5) increased with
time in the treated tumor. The average axial strain TC of the
treated tumor was found to be around s in the first week
and s in the third week while in the untreated tumor
the average axial strain TC was in the range s (in third
week). Since the Young’s modulus ( kPa) and Poisson’s
ratio ( ) did not change significantly (see Table I),
this increase in axial strain TC in the treated tumor was likely
to be attributed to a reduction of vascular permeability.
The bar plots of the fluid velocity (A1), fluid flow (A2),
axial strain TC (A3), (B1), ratio of VP and IP (B2) and
ratio of the peak IFP and effective vascular pressure (B3) are
shown in Fig. 3. These plots show mean value over standard
deviation of different parameters. Overall, based on the mean
values, fluid velocity, fluid flow and axial strain TC reduced
with time in the untreated tumors and increased with time in
the treated tumors.
The mean value of (B1) increased consistently with time
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Fig. 1: Ultrasound B-mode images of an untreated tumor at three time points (week 1, week 2 and week 3) are shown in A1,
B1 and C1, respectively. Fluid pressures at these time points are shown in A2, B2 and C2. Reconstructed fluid velocities inside
the tumor at the three time points are shown in A3, B3 and C3, respectively. Reconstructed fluid flows inside the same tumor
at three time points are shown in A4, B4 and C4, respectively. Axial strain TC elastograms of the same tumor estimated from
axial strain temporal curve at the three time points are shown in A5, B5 and C5, respectively. The fluid pressures and fluid
velocities are in scale of kPa and kPa per pixel, respectively. The length of each pixel is mm. The fluid flows are in
unit of milli-strain s . The unit of axial strain TC is second. The size of the tumor increased consistently from week 1 to
week 3 as seen from the B-mode images. The fluid pressure was very smooth and there was little spatial variation inside the
tumor especially at week 2 and week 3. The fluid velocity was very small at week 2 and week 3 for this tumor as seen in
(B3) and (C3). The fluid flow and axial strain TC seemed decreasing in value from week 1 to week 3.
in the untreated tumors whereas it decreased in the treated
tumors. The mean value of was lower for the treated tumors
than the untreated ones in the second and third weeks. Accord-
ing to previous literature [7], typically becomes higher as
a cancer progresses and decreases with treatment. The mean
ratio between VP and IP in untreated and treated tumors is
shown in Fig. 3 (B2). Similar to , the mean ratio between
VP and IP was much higher in the case of the untreated tumors
than the treated tumors in the second and third weeks. This
may indicate a net reduction of VP in treated tumors because
of drug administration as the administered drugs were reported
to have insignificant/no effect on IP [7]. In treated tumors, the
mean ratio between VP and IP decreased with time, whereas
it increased in untreated tumors, consistently with previous
observations [7]. The average values of the ratio between the
peak IFP and the effective vascular pressure at the different
time points are shown in Fig. 3 (B3). The mean value of this
ratio increased with time inside the untreated tumors, whereas
it decreased in the treated tumors. This implies that the IFP
increased in untreated tumors, while it decreased in treated
tumors if the effective vascular pressure is assumed constant
with time inside a tumor [46].
In Fig. 4 (A), (B) and (C), we report the Young’s modulus
and surface area of the tumors and surface area to volume
ratio of the capillary walls inside the tumors, respectively. Our
results show that Young’s modulus and surface area increased
and the mean surface area to volume ratio of the capillary
walls ( ) reduced with time in case of the untreated tumors,
whereas they remained almost constant in the treated ones.
Such changes in values of imply that the microvascular
density decreases with time in untreated tumors, while it
remains almost the same in treated tumors. This observation
correlates with results in the literature showing that tumor
microvascular density decreases with cancer progression [44].
V. DISCUSSION
In this paper, we developed methods to image fluid pressure,
fluid velocity, axial strain TC and fluid flow inside a tumor us-
ing ultrasound poroelastography techniques and demonstrated
the existence of a link between the estimated parameters
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Fig. 2: Ultrasound B-mode images of the first treated tumor at three time points (week 1, week 2 and week 3) are shown in
A1, B1 and C1, respectively. Fluid pressures at these time points are shown in A2, B2 and C2. Reconstructed fluid velocities
inside the tumor at the three time points are shown in A3, B3 and C3, respectively. Reconstructed fluid flows inside the same
tumor at three time points are shown in A4, B4 and C4, respectively. Axial strain TC elastograms of the same tumor estimated
from axial strain temporal curve at the three time points are shown in A5, B5 and C5, respectively. The fluid pressures and
fluid velocities are in scale of kPa and kPa per pixel, respectively. The length of each pixel is mm. The fluid flows are
in unit of milli-strain s . The unit of axial strain TC is second. Unlike the untreated tumors, the size of the treated tumor
decreased consistently from week 1 to week 3 because of treatment administration. The fluid pressure was spatially dependent
in the treated tumor in all three weeks which is in contrast with the untreated tumor. The fluid velocity was higher in case
of this treated tumor in comparison to the untreated one. The fluid flow and axial strain TC increased with time in treated
tumors, contrarily to the untreated tumors, where these parameters decreased with time.
TABLE I: Young’s modulus and Poisson’s ratio of treated and
untreated tumors at different time points
Sample Young’s modulus (kPa) Poisson’s ratio
Week 1 Week 2 Week 3 Week 1 Week 2 Week 3
Untreated tumor #1 63.54 77.61 97.12 0.29 0.25 0.24
Treated tumor #1 34.09 28.54 22.88 0.35 0.35 0.29
and the underlying tumor mechanopathological parameters.
Fluid pressure, fluid velocity and fluid flow estimated using
poroelastography can be used to assess the spatial distribution
of the actual underlying IFP, IFV and fluid flow parameters and
find regions in the tumor where these parameters are higher or
lower than average. This information could be of great clinical
significance for cancer diagnosis and treatment.
Several observations can be inferred from the results pre-
sented in this paper. In terms of the fluid velocity, we found
that fluid velocity was high inside treated tumors. This typi-
cally occurs when IFP is low and space-dependent inside the
tumor [32]. Due to the treatment, it may be possible that the
compressive stress in the tumor interstitium decreased and also
that the number of cancer cells and collagen deposition in
the tumor reduced (as the Young’s modulus of this tumor
decreased (see Table I)). A reduction of cell density and
collagen content may effectively improve the tortuosity of the
matrix, thus resulting in higher fluid velocities [47]. However,
in the case of untreated tumors in the third week, the fluid
velocity was found to be close to zero everywhere inside the
tumor. Such very low fluid velocity ( ) typically occurs
when the peak value of IFP is spatially constant and high
inside the tumor ( ).
Fluid flow is directly related to the outflow compliance of
the fluid (and/or drugs) from inside the tumor. In normal tis-
sues, the lymphatic vessels are intact and fully functional, IFP
is zero and the fluid flow is normal. In the cancer parenchyma,
because of the abnormal lymphatic vessels, contraction of
the vasculature due to solid stress and presence of elevated
IFP, the fluid flow is hampered and reduces in values [45],
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Fig. 3: (A1) Mean fluid velocities in unit of Pa per pixel inside the tumors of the treated and untreated tumors at week 1,
week 2 and week 3. (A2) Mean fluid flows inside the treated and untreated tumors at week 1, week 2 and week 3. The unit
of fluid flow is milli-strain per second. (A3) Mean axial strain TCs inside the treated and untreated tumors at week 1, week
2 and week 3. (B1) Mean values of inside the treated and untreated tumors at week 1, week 2 and week 3. (B2) Mean
ratios between the vascular and interstitial permeability inside the treated and untreated tumors at week 1, week 2 and week
3. (B3) Mean ratios between the peak IFP and effective vascular pressure inside the treated and untreated tumors at week 1,
week 2 and week 3. ‘n.s.’ means not statistically significant. One and two stars correspond to -value less than and ,
respectively. Based on only mean values, the fluid velocity, axial strain TC and fluid flow decreased with time in untreated
tumors and increased with time in the treated ones. On the other hand, the mean value of , ratio between the vascular and
interstitial permeability and ratio between the peak IFP and effective vascular pressure increased with time in untreated tumors
and decreased with time in the treated ones.
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Fig. 4: (A) Young’s modulus and (B) surface area of the tumors, (C) Surface area to volume ratio of the capillary walls inside
the tumors at three weeks. ‘n.s.’ means not statistically significant. One and two stars correspond to -value less than
and , respectively. Based on only mean values, the Young’s modulus and surface area of the untreated tumors increased
consistently with time, whereas values of these parameters remained almost same in the treated tumors with time. The surface
area to volume ratio of the capillary walls decreased in untreated tumors with time, whereas remained almost same in the
treated tumors at all time points.
[48]. This phenomenon appears to be confirmed by the in
vivo experimental results obtained in untreated animals (Fig. 3
(A2)). Knowledge of fluid flow in the tumors has been shown
to provide important information for drug delivery therapies
as the rate of fluid flow dictates the extravasation of drug
molecules from tumor tissue [49].
Another important result of our study relates to the potential
significance of axial strain TC images in cancer applications.
Using an analytical model of poroelastic response in spherical
tumors and knowledge of the aggregate modulus of the tumor,
in the future, it could be possible to determine both the IP and
VP of a tumor from the estimated axial strain TC elastograms
[35]. In addition, if the effect of IP can be assumed to be small
in comparison to that of VP inside the tumor [15], with known
values of the axial strain TC and the aggregate modulus inside
the tumor, we can estimate the VP using models described in
Ref. [35].
In this study, we reported a method to assess the parameter
, which dictates the spatial distribution of IFP inside a
tumor and, as such, can be used in designing drug delivery
techniques [7]. In tumors with large , the gradient of the
IFP is very small inside the tumor and very high at the
periphery. Therefore, most of the drug cannot reach the central
portion of the tumor and accumulates at the periphery [7].
If reduces, the gradient of the IFP (IFV) increases and
the drug has a better chance to reach the central portion
of the tumor. However, if becomes too low ( ), the
IFP becomes very small and the IFV again reduces and the
effective drug delivery gets hampered. Therefore, treatments
such as vascular normalization should be administered in such
a way that should be close to , so that proper drug delivery
may be achieved [7]. In tumors with low (close to ),
it is also possible that the flux of growth factors reaching
the draining lymph nodes is decreased due to less fluid flow
from the boundary [7], and it could also inhibit lymph node
lymphangiogenesis [50]. Lymph node lymphangiogenesis is
thought to potentially increase the incidence of lymph node
metastasis, by providing additional opportunities for the cells
to enter into the lymphatic system. Therefore, a low value of
may reflect in an improvement of the delivery/penetration
of therapeutics in tumors, alleviation of peritumoral fluid
accumulation, and, at the same time, decrease of the shedding
of cancer cells into peritumoral fluids or surrounding tissues.
In the past, methods to estimate have been proposed but
with some limitations. For example, the method proposed in
[33] requires values of IFP along the full radius of the tumor
to use least square fit on the spatial distribution of IFP. This
method produces erroneous results when the IFP is low/zero
inside the tumor or when all IFP values are not available along
the radius of the tumor. This may be the case, when IFP is
measured at discrete points inside the tumor such as in invasive
methods involving wick and needle/servo-micropipette [22]–
[24]. Our proposed method for estimation of does not
depend on the value of IFP inside the tumor and is able to
estimate even when the IFP is zero inside the tumor.
In this study, we showed that it is possible to estimate
9the ratio between VP and IP and the ratio between the peak
IFP and effective vascular pressure inside the tumor using
poroelastography. The ratio between VP and IP may be used
as a marker of the efficacy of certain cancer treatments. As
an example, if vascular normalization treatment is used and is
effective, this ratio may be expected to decrease [45]. Change
in the value of the ratio between peak IFP and effective
vascular pressure can be a direct indicator of the change in
the peak value of IFP inside the tumor, when the effective
vascular pressure (approximately equal to microvascular pres-
sure [7]) remains constant over time [46]. Along with all
the above-mentioned parameters, we also plotted the surface
area to volume ratio of the capillary walls, surface area and
Young’s modulus of the treated and untreated tumors to further
characterize the in vivo results.
The main limitation of the proposed approach is that the
reconstructed interstitial fluid pressure, fluid velocity and fluid
flow do not represent the actual values of IFP, IFV and fluid
flow inside the cancer tumor. Rather, they represent their
weighted values. However, based on the studies presented
in Refs. [7], [45], the spatial and temporal distributions of
these parameters can oftentimes be sufficient for diagnosis and
treatment planning of cancers even if the actual values may
be unknown.
VI. CONCLUSIONS
In this paper, we applied poroelastography-based methods to
determine fluid pressure, fluid velocity, , axial strain TC and
fluid flow inside a tumor as a result of an externally applied
compression. We proved mathematically that these estimated
parameters are related to the actual IFP, IFV, fluid flow, IP
and VP inside the tumors. Thus, the estimated parameters
using poroelastography may be of great clinical significance
for diagnosis, prognosis and treatment of cancers.
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1. Detail proofs of the formulations for estimation of the proposed parameters
A. Fluid pressure.
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B. Ratio between vascular permeability and interstitial permeability and parameter .
C. Ratio between peak IFP and effective vascular pressure.
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D. Fluid velocity.
E. Fluid flow.
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F. Axial strain time constant .
2. Validation of the proposed technique
A. Simulations.
A.1. Finite element simulations.
Fig. S1. (A) A schematic of a cylindrical sample of a poroelastic material with a spherical inclusion of radius . The axial direction is along the -axis. Inside the inclusion,
indicates the radial direction. (B) The 2D solution plane for the three dimensional sample. The sample is compressed between two compressor plates. The compression is
applied along the direction.
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Table S1. Mechanical parameters of samples A and B
Sample name (kPa) (kPa) (m N s ) m N s (Pa s) (Pa s)
A 32.78 97.02 0.49 0.47
B 32.78 97.02 0.49 0.47
A.2. Ultrasound simulations.
Fig. S2. Fluid pressure from FEM and fluid pressure estimated by the proposed method using the FEM axial and lateral strains at time points of s, s and s for
sample A are shown in (A1-A3) and in (B1-B3) respectively. Fluid pressure estimated by the proposed method using ultrasound simulated axial and lateral strains at time
points of s, s and s for sample A are shown in (C1-C3). The unit of fluid pressure is Pa.
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Fig. S3. Fluid velocity from FEM and fluid velocity estimated by the proposed method using the FEM axial and lateral strains at time points of s, s and s for sample
A are shown in (A1-A3) and in (B1-B3) respectively. Fluid velocity estimated by the proposed method using ultrasound simulated axial and lateral strains at time points of s,
s and s for sample A are shown in (C1-C3). The unit of fluid velocity is Pa cm .
Fig. S4. Fluid pressure from FEM and fluid pressure estimated by the proposed method using the FEM axial and lateral strains at time points of s, s and s for
sample B are shown in (A1-A3) and in (B1-B3) respectively. Fluid pressure estimated by the proposed method using ultrasound simulated axial and lateral strains at time
points of s, s and s for sample B are shown in (C1-C3). The unit of fluid pressure is Pa.
B. Results.
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Fig. S5. Fluid velocity from FEM and fluid velocity estimated by the proposed method using the FEM axial and lateral strains at time points of s, s and s for sample
A are shown in (A1-A3) and in (B1-B3) respectively. Fluid velocity estimated by the proposed method using ultrasound simulated axial and lateral strains at time points of s,
s and s for sample B are shown in (C1-C3). The unit of fluid velocity is Pa cm .
Islam et al. 7 of 8
Fig. S6. Curve fitting for computing from radial profile of fluid pressure (FP) estimated from FEM strain data of sample A (A) and sample B (B). Curve fitting for computing
from radial profile of fluid pressure estimated from ultrasound simulated (US) strain data of sample A (C) and sample B (D).
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